AI-powered fact-checking for competitive intelligence decks

Keep your decks accurate
and up to date

FactRefresh scans your competitive intelligence decks against the latest data, flagging outdated claims and suggesting corrections with cited sources — with search criteria tuned to your field, whether that's pharma, private equity, or one you build yourself.

See it in action

A 90-second walkthrough of reviewing an analysed deck. It uses our worked example, so the companies, products and sources in it are fictional.

Everything you need to keep decks current

Purpose-built for competitive intelligence teams, whatever field you work in.

AI-Powered Analysis

Upload PPTX or PDF decks and let our AI review every claim against current web sources.

Source Citations

Suggestions come with links to the sources behind them. The few that have none say so, and say why, before you accept anything.

Tuned to your field

Adjustable search criteria for your industry — pharma, private equity, and general business out of the box. Tune the terms to your field, or build your own pack from scratch.

What you get back

A queue of specific, sourced changes to accept or reject, one slide at a time. These are real suggestions from a real run.

Correction
Original

With a US NDA currently under Priority Review, sevabertinib could gain FDA approval by year-end as a second oral alternative.

Suggested

Sevabertinib (HYRNUO) received FDA accelerated approval on November 19, 2025 for previously treated HER2-mutant non-squamous NSCLC, making it an in-market second oral HER2 TKI rather than a pending approval.

The slide treats sevabertinib's US approval as a future possibility, but it has already been approved.

AcceptReject1 source
Missing from slide
Add to slide

Add that Beamion LUNG-1 (P1b) reported 77% confirmed ORR, 96% DCR and 79% 6-month PFS in treatment-naive HER2-mutant NSCLC patients (ESMO 2025), the data underpinning zongertinib's 1L approval.

This is the key efficacy data supporting zongertinib's expanded 1L label and is not reflected on the slide.

AcceptReject1 source

Output from a benchmark run on a HER2 competitive deck, unedited.

Hours of research become minutes of review

FactRefresh does the searching for you. You still decide what goes on each slide, and you just stop hunting for what changed.

Refreshing a 15-slide deck by hand

1.5 to 2.5 hrs

Identify every asset, trial and company on each slide. Search for what has happened since the last refresh. Read the sources. Decide what actually changed.

With FactRefresh

~20 min

Eight to ten minutes unattended while the deck is analysed, then ten to fifteen reviewing a queue of sourced suggestions and accepting the ones that hold up.

The analysis time is measured over three runs of a 14-page deck. The manual figure is an estimate: we assume six to ten minutes per content slide to research and verify it by hand, which is conservative for regulatory claims that need checking across several agencies. Your own decks will differ.

How it works

Three simple steps to always-current slide decks.

01

Upload your deck

Upload any PPTX or PDF presentation. FactRefresh extracts text, claims, and speaker notes automatically.

02

AI analyzes every claim

Our AI searches the web for what has happened since your last refresh, and cross-references each claim against what it finds.

03

Review & accept updates

Review suggested changes side-by-side with source citations. Accept, reject, or modify each suggestion.

Ready to streamline your deck reviews?

Explore a full worked example deck, then analyse your first three slides free. No credit card required.

Request access